TY  - GEN
AU  - Styler,M J
AU  - Crilley,P
AU  - Biggs,J
AU  - Moul,J
AU  - Copelan,E
AU  - Topolsky,D
AU  - Avalos,B
AU  - Penza,S
AU  - Sabol,P
AU  - Downs,K
AU  - Szer,J
AU  - Brodsky,I
AU  - Marks,D I
TI  - Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis
SN  - 0268-3369
PY  - 1997///0227
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Anti-Bacterial Agents
KW  - adverse effects
KW  - Bone Marrow Transplantation
KW  - Busulfan
KW  - Child
KW  - Child, Preschool
KW  - Ciprofloxacin
KW  - Cyclophosphamide
KW  - Estrogens
KW  - Female
KW  - Genetic Diseases, Inborn
KW  - therapy
KW  - Graft vs Host Disease
KW  - prevention & control
KW  - Hepatic Veno-Occlusive Disease
KW  - chemically induced
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Incidence
KW  - Life Tables
KW  - Liver Diseases
KW  - complications
KW  - Liver Function Tests
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Multiple Organ Failure
KW  - Multivariate Analysis
KW  - Neoplasms
KW  - Progestins
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Transplantation Conditioning
KW  - Vancomycin
N1  - Publication Type: Journal Article; Multicenter Study
ER  -